Jianbin Wang

Title: Innovations of Jianbin Wang in Glutaminase C Inhibition

Introduction

Jianbin Wang is an accomplished inventor based in Ithaca, NY (US). He has made significant contributions to the field of biochemistry, particularly in the inhibition of glutaminase C. With a total of 2 patents, his work has the potential to impact various therapeutic approaches.

Latest Patents

Wang's latest patents focus on the inhibition of glutaminase C. The first patent describes a method for reducing the production of glutamate from glutamine by inhibiting glutaminase C activity in a cell or tissue. This method is effective under specific conditions that reduce glutamate production. Additionally, the patent discloses various compounds that can be used to carry out this method. The second patent mirrors the first, emphasizing the importance of glutaminase C inhibition and detailing compounds of formula (III) for practical application.

Career Highlights

Jianbin Wang is affiliated with Cornell University, where he conducts his research and development. His work at this prestigious institution has allowed him to explore innovative solutions in the realm of biochemistry. His research has garnered attention for its potential applications in medical science.

Collaborations

Wang has collaborated with notable colleagues, including Richard A Cerione and Jon W Erickson. These partnerships have enriched his research endeavors and contributed to the advancement of knowledge in his field.

Conclusion

Jianbin Wang's contributions to the inhibition of glutaminase C represent a significant advancement in biochemistry. His patents and research at Cornell University highlight his commitment to innovation and the potential for therapeutic applications.